Investors Are Betting On Devices That Connect the Brain to Computers

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-24T11:10:16.086Z • Permanent link

Bill Ackman, billionaire investor and founder of Pershing Square Capital Management, has joined the ranks of tech moguls Elon Musk and Jeff Bezos in backing Precision Neuroscience, a company developing devices that connect the human brain to computers. Precision Neuroscience has been working on its Neuralink technology since 2016, and its product is expected to revolutionize the way we interact with devices. The company has already secured funding from some of the biggest names in tech, including Google and Facebook. Musk, who has also been involved in the development of Neuralink, has stated that the technology has the potential to treat a range of medical conditions, including paralysis and depression. Bezos, on the other hand, has expressed interest in using the technology to enhance human cognition and potentially even achieve a form of immortality. Ackman's investment in Precision Neuroscience is seen as a vote of confidence in the company's mission and its potential to disrupt the global healthcare and technology industries.

Precision Neuroscience's technology is based on a tiny chip that is implanted into the brain, allowing people to control devices with their thoughts. The chip is connected to the brain through a series of electrodes and is powered by a small battery. The company has already conducted several successful trials with its technology, including a study that showed patients with paralysis were able to control a computer cursor with their thoughts. The company is now working to refine its technology and make it available to the general public. The FDA has already given its approval for the use of Neuralink technology in human clinical trials, and the company is expected to start selling its products in the next few years.

Investors are also taking notice of Precision Neuroscience's progress, with the company's valuation expected to reach $1 billion by the end of the year. The company's success has also sparked interest from governments and research institutions around the world, with several countries already investing in similar technologies. The global healthcare industry is expected to be a major beneficiary of Precision Neuroscience's technology, with the company's products expected to revolutionize the way we treat medical conditions such as paralysis, depression, and anxiety.

Precision Neuroscience's technology has the potential to disrupt several major industries, including healthcare, technology, and finance. The company's products are expected to be used in a range of applications, from treating medical conditions to enhancing human cognition. The company's success has also sparked interest from research communities around the world, with several institutions already investing in similar technologies. The impact of Precision Neuroscience's technology on the global economy is expected to be significant, with the company's products expected to create new job opportunities and stimulate innovation.

The success of Precision Neuroscience's technology also raises important questions about the ethics of brain-computer interfaces. As the technology becomes more advanced, there is a risk that it could be used to manipulate people's thoughts and actions. The company's founders have stated that they are committed to ensuring that their technology is used for the benefit of humanity, but there is still much to be learned about the long-term implications of brain-computer interfaces. As a result, regulatory bodies around the world are already taking steps to ensure that the technology is used responsibly.

Precision Neuroscience's technology is part of a larger trend in the tech industry, with several companies already working on similar technologies. Companies such as Facebook and Google have already developed brain-computer interfaces, and several research institutions are working on similar technologies. However, Precision Neuroscience's technology is unique in its approach, using a tiny chip implanted into the brain to control devices. This approach is different from other technologies, which use external sensors to detect brain activity.